The pharmaceutical provide chain is continuously evolving in response to breakthroughs in technologies, shifting industry dynamics, and emerging healthcare trends.“We have to find a way to supply added incentives for manufacturing to return to the US. Whichever those economic incentives are, the government will have to get started getting it crit